The global acute kidney injury (AKI) treatment market is set to grow from US$2.23 billion in 2024 to US$3.70 billion by 2031, driven by a robust CAGR of 7.5%. This expansion is fueled by rising incidences of sepsis, cardiac complications, and drug toxicity, along with an aging population more prone to renal issues. Advancements in pharmacological treatments, renal replacement...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian